Table 1.
Scoring of the decision alternatives against the evaluation criteria.
| Preference direction | Primary prevention | Secondary prevention | Tertiary microvascular prevention | Tertiary macrovascular prevention | |
|---|---|---|---|---|---|
| Reduction in downstream healthcare costs | Increasing | € 658M | € 0 | € 73M | € 312M |
| Added quality-adjusted survival | Increasing | € 280K | € 0 | € 1K | € 80K |
| Cost of related intervention | Decreasing | € 792 | € 663 | € 155 | € 561 |
| Feasibility of treat-all option | 2 | 1 | 4 | 3 | |
| Performance of existing tests | 3 | 4 | 1 | 2 | |
| Ease of implementation | 2 | 2 | 1 | 1 |